Insightec Announces Exablate Prime Availability In Europe -The next generation Of MR-guided focused ultrasound
Insightec reaffirms its position at the forefront of the medical technology industry with improved functionality, safety features, and…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
17 Apr 24
Insightec reaffirms its position at the forefront of the medical technology industry with improved functionality, safety features, and…
16 Apr 24
The multicentre, randomised, placebo-controlled APPLAUSE-IgAN trial recruited 518 adult patients with primary IgAN, who were given twice-daily doses…
12 Apr 24
Greenspace's measurement-based care platform will integrate with Welligent's cloud-based EHR software for behavioural health.
04 Apr 24
The approval for Zevtera was based on the clinical efficacy and safety data from the Phase 3 ERADICATE…
03 Apr 24
Under the deal, Genmab will gain global rights to ProfoundBio’s portfolio of next-generation ADCs which consists of three…
02 Apr 24
STRO-003, which is currently in the final stages of pre-clinical development, targets the ROR1 tumour antigen, which is…
Patient CarePharmaceuticals and MedicinesPartnerships and Licensing Agreements
01 Apr 24
Developed by Eisai and Biogen, Leqembi is humanised IgG1 monoclonal antibody indicated as an AD therapy for patients…
28 Mar 24
The approval is supported by the safety and efficacy data from the INNO2VATE programme and post-marketing safety data…
28 Mar 24
Chubb today announced the launch of a new HealthTech industry practice in the UK.
26 Mar 24
The acquisition is expected to advance Nuvation Bio as a late-stage, international oncology firm in which its current…